Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Collplant Biotechnologies Ltd CLGN

Healthcare Biotechnology
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I... see more

Recent & Breaking News (NDAQ:CLGN)

Termination of Licensing Agreement for Bioprinting of Scaffolds for Lung Transplants

PR Newswire February 25, 2021

CollPlant Issues Letter to Shareholders

PR Newswire February 18, 2021

CollPlant Announces Closing of $35.0 Million Registered Direct Offering of American Depositary Shares

GlobeNewswire February 18, 2021

CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares

GlobeNewswire February 11, 2021

CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products

PR Newswire February 8, 2021

3D Systems Announces Breakthrough in Bioprinting Technology and Expansion of Regenerative Medicine Initiative

GlobeNewswire January 27, 2021

CollPlant to Supply rhCollagen to STEMCELL Technologies for Use in a Broad Range of Cell Culture Applications

PR Newswire December 10, 2020

CollPlant Biotechnologies Reports Third Quarter (Q3) 2020 Financial Results and Provides Business Update

PR Newswire December 1, 2020

CollPlant Announces Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients

PR Newswire November 10, 2020

CollPlant Receives Substantial First Order for its Vergenix(TM) Flowable Gel Product in Ukraine

PR Newswire October 26, 2020

CollPlant and United Therapeutics Announce Exercise of Option that will Expand their Collaboration to Include 3D Bioprinting of Human Kidneys for Transplant

PR Newswire September 21, 2020

CollPlant Biotechnologies Presents on the Use of Novel, Plant-Derived, Recombinant Human Collagen for Anti-Aging Therapies at the Science of Aging Virtual Symposium 2020

PR Newswire September 16, 2020

CollPlant Biotechnologies Signs Distribution Agreement for its Vergenix Flowable Gel Product in the Commonwealth of Independent States (CIS)

PR Newswire September 14, 2020

CollPlant Biotechnologies to Present at Science of Aging Virtual Symposium 2020 During Healthy Aging Month

PR Newswire August 31, 2020

CollPlant Biotechnologies Reports Second Quarter (Q2) 2020 Financial Results

PR Newswire August 28, 2020

CollPlant Biotechnologies Reports First Quarter (Q1) 2020 Financial Results

PR Newswire May 27, 2020

Collplant to Host Webinar Highlighting its Plant-based, Human Recombinant Collagen (rhCollagen) Platform for the Future of Aesthetic and Regenerative Medicine

PR Newswire May 5, 2020

CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2019

PR Newswire April 1, 2020

CollPlant Biotechnologies Raising $4.45 Million in U.S. Private Placement

PR Newswire February 14, 2020

CollPlant Launches New Corporate Website to Showcase Recent Developments in Core Business Segments

PR Newswire February 4, 2020